Mangoceuticals CEO to Feature in Upcoming Interview at Nasdaq MarketSite Studio on Fox Business, Bloomberg TV, and Newsmax TV

MGRX’s CEO, Jacob Cohen returns to the Nasdaq MarketSite Studio to begin filming a Multi-Part TV Series with New to The Street discussing MangoRx

Dallas, Texas, June 22, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling multiple men's health and wellness products through a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ED) drug, "Mango,", is pleased to announce the upcoming filming of a TV interview as part of a Multi-Part TV Series on FMW Media's "New To The Street" business TV show featuring CEO, Jacob Cohen, which will air on Fox Business Network, Bloomberg TV (as a sponsored program) and NewsMax TV (through its syndicated and sponsored networks).

On Monday July 10th, 2023, Jane King, the host of "New To The Street", will sit down with Mr. Cohen to discuss the rapidly growing men’s health and wellness market, learn more about the Company’s current Mango ED products, and explore the Company’s plans for both the near term and long term future. This interview will the first of a three-part series and will be aired on the Fox Business Network, Bloomberg TV (as sponsored program) and NewsMax TV (through its syndicated and sponsored networks).

“I’m excited for the opportunity to sit down with renowned host and journalist, Jane King, to share more about the dramatic strides we have been making at MangoRx as well as the exciting path we see ahead of us,” commented Jacob Cohen, CEO and Co-Founder of Mangoceuticals, Inc. “We have accomplished so much in such a short period of time, and we have some big steps just ahead as the health, wellness, and direct-to-consumer telemedicine industry continues to experience rapid growth. This interview will also allow me to share more about the upcoming release of our second Mango ED product, which leverages Sildenafil—the active ingredient found in Viagra—alongside our existing custom compound of Oxytocin and L-Arginine, as well as our plans to introduce additional products into the marketplace.”

The Interview will be filmed at the Nasdaq MarketSite Studio in Times Square and exact dates and air times of the interview will be made available and released shortly after the interview has been completed.

About Mango

Created using a special formulation featuring the same active ingredient as in Cialis (Tadalafil), each part of the Mango formulation plays a critical role in helping men achieve optimum performance. We believe the key to our success lies in our unique blend of ingredients, which are used in U.S. Food and Drug Administration (“FDA”) approved drugs. Mango contains a combination of Tadalafil, Oxytocin, and L-Arginine that have been traditionally used to treat sexual dysfunction.